TrialThe Lancet. Oncology2016

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Jaap C Reijneveld et al.PubMed ↗Publisher ↗

No numbers read from the abstract.